FilingIndex
10-KThe Record

Ultragenyx Pharmaceutical Inc. files 10-K

Filed Feb 17, 2017 · 9y ago · Accession 0001564590-17-001714

Plain English

Annual report — full-year financials, business overview, and risk factors.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
RARE
CIK
1515673
Form type
10-K
Filing date
Feb 17, 2017
Report date
Dec 31, 2016
Document
rare-10k_20161231.htm
Size
12.0 MB